[ Price : $8.95]
Federal Register notice: FDA withdraws approval of Cubist Pharmaceuticals Entereg (alvimopan) capsules because it is no longer mar...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Bausch + Lombs eye drug Mie...[ Price : $8.95]
Federal Register notice: FDA debars Ryan Stabile for 15 years from importing or offering for import any drug into the U.S.[ Price : $8.95]
Two Sheppard Mullin attorneys say sponsors of drugs approved through expedited pathways should learn from a recent FDA untitled le...[ Price : $8.95]
FDA clears Cresilons Traumagel device that uses a plant-based technology to control moderate to severe bleeding at the point of ca...[ Price : $8.95]
FDA describes CDERs new state-of-the-art advanced manufacturing research facility.[ Price : $8.95]
FDA accepts for priority review an AstraZeneca supplemental BLA for Imfinzi (durvalumab) and its use in certain patients with limi...[ Price : $8.95]
FDA grants Wave Life Sciences a rare pediatric disease designation for WVE-N531 and its use in treating boys with Duchenne muscula...